Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clinical Trial Modernization, Outsourcing Concerns Are Focus Of FDA/Duke Effort

Executive Summary

In an FDA-Duke University Medical Center partnership to modernize the way clinical trials are conducted, close attention will be paid to the increase of outsourcing and off-shoring clinical trials

You may also be interested in...



Public/Private Initiative To Help FDA Modernize Guidance For Clinical Trials

Output from the Clinical Trials Transformation Initiative, whose executive board was named May 5, is expected to lead to new FDA clinical trial guidance

Public/Private Initiative To Help FDA Modernize Guidance For Clinical Trials

Output from the Clinical Trials Transformation Initiative, whose executive board was named May 5, is expected to lead to new FDA clinical trial guidance

Sponsors Often Compromise Ethics For Cost Efficiency With Trial Outsourcing

As drug sponsors opt to cut costs by outsourcing clinical trials to emerging nations such as India, incomplete patient consent forms are one of several rising ethical concerns linked to such demand

UsernamePublicRestriction

Register

PS049069

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel